Evidence map›Paper›PMID 22155105›Full record

ArticleCancer letters2012

B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer.

Vinita Singh-Gupta, Sanjeev Banerjee, Christopher K Yunker, Joseph T Rakowski, Michael C Joiner, Andre A Konski, Fazlul H Sarkar, Gilda G Hillman

Abstract read
In one paragraph

Article in Cancer letters, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Vinita Singh-GuptaDepartment of Radiation Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Sanjeev Banerjee
Christopher K Yunker
Joseph T Rakowski
Michael C Joiner
Andre A Konski
Fazlul H Sarkar
Gilda G Hillman
The Barbara Ann Karmanos Cancer Institute · USWayne State University · US

Funding

Novel Targets of Indoles in Prostate CancerR01CA108535 · NCI · WAYNE STATE UNIVERSITY · PI SARKAR, FAZLUL H. · 2004 to 2014
$2.7M
NCI NIH HHS R01 CA108535NCI NIH HHS R01CA108535-06
6 · The paper itself

Abstract

Increased consumption of cruciferous vegetables is associated with decreased risk in prostate cancer (PCa). The active compound in cruciferous vegetables appears to be the self dimerized product [3,3'-diindolylmethane (DIM)] of indole-3-carbinol (I3C). Nutritional grade B-DIM (absorption-enhanced) has proven safe in a Phase I trial in PCa. We investigated the anti-cancer activity of B-DIM as a new biological approach to improve the effects of radiotherapy for hormone refractory prostate cancer cells, which were either positive or negative for androgen receptor (AR) expression. B-DIM inhibited cell growth in a dose-dependent manner in both PC-3 (AR-) and C4-2B (AR+) cell lines. B-DIM was effective at increasing radiation-induced cell killing in both cell lines, independently of AR expression. B-DIM inhibited NF-κB and HIF-1α DNA activities and blocked radiation-induced activation of these transcription factors in both PC-3 and C4-2B cells. In C4-2B (AR+) cells, AR expression and nuclear localization were significantly increased by radiation. However, B-DIM abrogated the radiation-induced AR increased expression and trafficking to the nucleus, which was consistent with decreased PSA secretion. In vivo, treatment of PC-3 prostate tumors in nude mice with B-DIM and radiation resulted in significant primary tumor growth inhibition and control of metastasis to para-aortic lymph nodes. These studies demonstrate that B-DIM augments radiation-induced cell killing and tumor growth inhibition. B-DIM impairs critical survival signaling pathways activated by radiation, leading to enhanced cell killing. These novel observations suggest that B-DIM could be used as a safe compound to enhance the efficacy of radiotherapy for castrate-resistant PCa.

Indexed as

AnimalsAnticarcinogenic AgentsApoptosisBlotting, WesternCell CycleCell Line, TumorCell ProliferationElectrophoretic Mobility Shift AssayFluorescent Antibody TechniqueHumansHypoxia-Inducible Factor 1, alpha SubunitIndolesMaleMiceMice, NudeNF-kappa B3,3'-diindolylmethaneAnticarcinogenic AgentsAR protein, humanHypoxia-Inducible Factor 1, alpha SubunitIndolesNF-kappa BProstate-Specific AntigenReceptors, Androgen

Identifiers

PMID22155105
PMCPMC3288414
OpenAlexW2039412611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.